High levels of catalytic antibodies correlate with favorable outcome in sepsis. - Wikidata - wikimedia - TriplyDB

High levels of catalytic antibodies correlate with favorable outcome in sepsis.

High levels of catalytic antibodies correlate with favorable outcome in sepsis.

http://www.wikidata.org/entity/Q33932633

about

Need for a paradigm shift in therapeutic approaches to CNS injury Strain-specific virulence phenotypes of Streptococcus pneumoniae assessed using the Chinchilla laniger model of otitis media Immunological origin and functional properties of catalytic autoantibodies to amyloid beta peptide.IVIg treatment reduces catalytic antibody titers of renal transplanted patients Autoantibodies with enzymatic properties in human autoimmune diseases.DNA-hydrolysing activity of IgG antibodies from the sera of patients with diseases caused by different bacterial infections.Constitutive production of catalytic antibodies to a Staphylococcus aureus virulence factor and effect of infection.Antibodies to H1 histone from the sera of HIV-infected patients recognize and catalyze site-specific degradation of this histone.Constant domain-regulated antibody catalysis.Identification and Characterization of the Trypanosoma cruzi B-cell Superantigen Tc24 Generation of Catalytic Antibodies Is an Intrinsic Property of an Individual's Immune System: A Study on a Large Cohort of Renal Transplant Patients.Affinity and catalytic heterogeneity of polyclonal myelin basic protein-hydrolyzing IgGs from sera of patients with multiple sclerosis Formation of different abzymes in autoimmune-prone MRL-lpr/lpr mice is associated with changes in colony formation of haematopoietic progenitors.Sepsis biomarkers: a review.Do proteolytic antibodies complete the panoply of the autoimmune response in acquired haemophilia A?Antibody-antigen pair probed by combinatorial approach and rational design: bringing together structural insights, directed evolution, and novel functionality.B-cell-mediated strategies to fight chronic allograft rejection IL-10-independent regulatory B-cell subsets and mechanisms of action.Selective Photocatalytic Disinfection by Coupling StrepMiniSog to the Antibody Catalyzed Water Oxidation Pathway.Antibody-Mediated Catalysis in Infection and Immunity.Antibodies to H2a and H2b histones from the sera of HIV-infected patients catalyze site-specific degradation of these histones.A human germ line antibody light chain with hydrolytic properties associated with multimerization status.Generation, characterization, and docking studies of DNA-hydrolyzing recombinant F(ab) antibodies.A metalloantibody that irreversibly binds a protein antigen.Hydrolysis of factor VIII mediated by catalytic antibodies occurs in haemophilia A patients with or without factor VIII inhibitors.Factor VIII-hydrolyzing IgG in acquired and congenital hemophilia.IgG antibodies with peroxidase-like activity from the sera of healthy Wistar rats.Autoantibody-catalyzed hydrolysis of amyloid beta peptide.Anti-integrase abzymes from the sera of HIV-infected patients specifically hydrolyze integrase but nonspecifically cleave short oligopeptides.Substrate specificity of healthy human sera IgG antibodies with peroxidase and oxydoreductase activities.Affinity and catalytic heterogeneity and metal-dependence of polyclonal myelin basic protein-hydrolyzing IgGs from sera of patients with systemic lupus erythematosus.Diagnostics of autoimmune neurodegeneration using fluorescent probing Catalytic antibodies in patients with systemic lupus erythematosus Emergence of autoantibodies to HMGB1 is associated with survival in patients with septic shock Catalytic antibodies from HIV-infected patients specifically hydrolyzing viral integrase suppress the enzyme catalytic activities

P2860

Q27025042-6514C557-C090-40E5-B00A-65E6FBB7E075 Q33327378-A5B24585-E6FD-4AF7-B13E-1C820ADC7A81 Q33573668-506B4522-9DD5-48A6-96A0-DAA4DC4FF1AD Q34962680-1D326F1C-E8E4-44C0-9B5B-6C9B81AFAF4E Q35214200-6527D505-ADA5-4D59-AB51-B49638C36FFF Q35841936-63386AE8-9875-40D3-AB5C-FD34597CC0B4 Q35880109-4D057413-CB2D-409F-96A3-393DDBDCFCEE Q36197918-140F12B1-75BA-470E-89CB-C7E523D3A8E9 Q36332826-A95D8F6D-1254-41F9-8BD2-0DA751F3C5DD Q36455741-AA312146-93A0-4D71-9323-10CD9CD63C85 Q36905946-985AF7C6-5844-44FD-A048-8B45E9D656E6 Q37296340-0C6DBC3F-3742-4549-9EDF-78465BC8BDB1 Q37580191-4AAB48A4-15DB-46E2-AE07-9F54183079A4 Q37689825-A9C13B5A-58AB-4AF0-9140-079F0A1A9757 Q37944291-76026422-70E9-4E89-97CD-B601689779EC Q38030235-E1060A58-984B-487E-A217-01BFFF494D5B Q38175026-F8549FB3-DF6F-4A1F-A1DE-EBB85BB1A0C1 Q38497062-9445E2BC-CD91-4F9F-960A-233C4921EDE2 Q39401709-2407BBA5-8E88-4346-B971-748BBFFB5AB4 Q39412526-AE0DA7EB-C3FF-461A-A807-78BD45529822 Q40234883-B8414BDD-1BD1-4CB3-9D76-099A2250DBDB Q42680119-5ABE82BE-4221-41D9-B47A-6EACBE2C3574 Q42798552-D0D46C0A-4669-4BFB-A2E3-30FAC2FE5DC6 Q43808918-934AA81B-2A6D-455D-8E0A-B42518D4D3A1 Q45883602-014A1E77-C59F-4BA7-87C4-E81E54307DE4 Q45886858-31438478-5C24-4A34-AABF-4DA7B46F7AD5 Q46580184-1E99178E-2391-48C7-BA2F-137F5B2AE989 Q46845401-F10BB21E-208F-4D3A-8EE6-C8BEA7DCA677 Q47998913-E69AE807-FBB7-4FAC-B48F-EB2C120D4101 Q48094602-A4FEE340-5D6C-4104-A596-9E4CB4C9B7B5 Q53209420-12A99324-B634-448A-9238-D5B8F112941C Q58714753-A5CF6EAD-AF84-4E14-AF3B-618B80F4B742 Q58796857-2AB14EF6-EF27-4ED7-BBA5-B01205806FA4 Q58861244-0CC8D544-470A-4C09-81B8-150114677EE8 Q59084568-477024AB-2ECA-437E-9CBC-95779251FB38

P2860

High levels of catalytic antibodies correlate with favorable outcome in sepsis.

http://www.wikidata.org/entity/Q33932633

description

2005 nî lūn-bûn

@nan

2005 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի մարտին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

High levels of catalytic antibodies correlate with favorable outcome in sepsis.

@ast

High levels of catalytic antibodies correlate with favorable outcome in sepsis.

@en

type

label

High levels of catalytic antibodies correlate with favorable outcome in sepsis.

@ast

High levels of catalytic antibodies correlate with favorable outcome in sepsis.

@en

prefLabel

High levels of catalytic antibodies correlate with favorable outcome in sepsis.

@ast

High levels of catalytic antibodies correlate with favorable outcome in sepsis.

@en

P1433

Q33932633-B7779159-8BDF-4260-A0D5-CCFE55F5E88C

P1476

Q33932633-F1516E9A-C9B8-4554-9624-08747F42499E

P2093

Q33932633-32F77D4F-C21F-4F7D-8DBE-07CE4DA17F99

Q33932633-412EEC15-D87B-45A8-8CDD-14249510A2CE

Q33932633-450B6A6E-1B23-467E-A838-E436C359127A

Q33932633-7774FC76-B0BA-48E4-ACFD-9AF49F2625FC

Q33932633-9D1B7281-6AC1-4762-9B8F-27E0E99C2766

Q33932633-9F2C49F7-4FBF-4ABB-8429-45E5D334BAC1

Q33932633-D3893097-9D0B-4FE4-9D64-0ED6B378C671

Q33932633-D4640218-DE74-4938-AD49-9D1D0542E9FF

Q33932633-F28D9C54-0CEA-4BD8-8A4D-A52F94419912

P2860

Q33932633-02084F33-E178-4FB0-BC39-CF553CB8AF01

Q33932633-06EB8720-232F-412C-B0BD-B8F9961DDC31

Q33932633-0B5CB744-6C9D-4B81-B951-AE14B493A42B

Q33932633-0F90E16F-643E-4F30-B8DB-4C005A8045D5

Q33932633-112BF757-ECB9-48FD-9F3C-86088D302631

Q33932633-12D425F2-E900-417D-A6A8-FA68DA4CDC15

Q33932633-2BE82535-0476-4564-9211-F60E44919382

Q33932633-327D630F-1C87-490D-9382-2F82C82C574F

Q33932633-3D0E8791-5C34-433B-8200-0C9D1B93BBE0

Q33932633-4153830D-96FA-4455-8BBF-B8D5F81030B6

P304

Q33932633-49BEE2D2-1EE4-49D2-B297-7749C28C5EF5

P31

Q33932633-35C5D6E7-E5F6-4734-BC42-1852EA1C31D8

P356

Q33932633-7DB1ED42-3AAD-4C24-B0A7-6BAAF3BC40DA

P407

Q33932633-39AEB436-4CED-4ADD-BD74-9CA66E51F729

P433

Q33932633-59F45C6C-E25B-45F4-AD60-07239C464984

P478

Q33932633-40C351BD-F0D1-4356-B481-3A262F023B7E

P50

Q33932633-4B31065C-18E9-45A3-9C0F-D420323EB240

Q33932633-685D4FD1-317F-4D93-B75E-AB2EC15E3B1C

Q33932633-D6246FC4-3BD8-453A-81C6-B4D92B4048A0

P577

Q33932633-271A32B4-5469-40E2-BD23-8F39C4AF9440

P5875

Q33932633-40FF93AC-9BF5-4404-9334-1FC1C56399AA

P698

Q33932633-BD4AC363-2CF4-475E-8F25-A657534A3E88

P921

Q33932633-53C2DDDC-9E47-4C4A-B7A7-501E44B79FCB

Q33932633-631A4017-0C8F-4B9F-8595-E4527896C927

P932

Q33932633-0BB80FFE-5FA8-4576-8C81-00D51863CED2

P356

PNAS.0500586102

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

High levels of catalytic antibodies correlate with favorable outcome in sepsis

@en

P2093

Charles-Edouard Luyt

http://www.w3.org/2001/XMLSchema#string

David Hayon-Sonsino

http://www.w3.org/2001/XMLSchema#string

Jean-François Dhainaut

http://www.w3.org/2001/XMLSchema#string

Jean-Paul Mira

http://www.w3.org/2001/XMLSchema#string

Julien Charpentier

http://www.w3.org/2001/XMLSchema#string

Michel D Kazatchkine

http://www.w3.org/2001/XMLSchema#string

Nithyananda Thorenoor

http://www.w3.org/2001/XMLSchema#string

Srini V Kaveri

http://www.w3.org/2001/XMLSchema#string

Valakunja Nagaraja

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy and safety of recombinant human activated protein C for severe sepsis

Toll-like receptors: critical proteins linking innate and acquired immunity

Complement-independent, peroxide-induced antibody lysis of platelets in HIV-1-related immune thrombocytopenia.

Evidence for antibody-catalyzed ozone formation in bacterial killing and inflammation.

DNA hydrolyzing autoantibodies.

Cleavage of supercoiled plasmid DNA by autoantibody Fab fragment: application of the flow linear dichroism technique

Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin.

Endotoxin shock in antibody-deficient mice: unraveling the role of natural antibody and complement in the clearance of lipopolysaccharide.

Unexpectedly high occurrence of catalytic antibodies in MRL/lpr and SJL mice immunized with a transition-state analog: is there a linkage to autoimmunity?

Invasive aspergillosis in 2002: an update.

P304

4109-4113

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0500586102

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

102

http://www.w3.org/2001/XMLSchema#string

P50

Jagadeesh Bayry

Sébastien Lacroix-Desmazes

P577

2005-03-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7989993

http://www.w3.org/2001/XMLSchema#string

P698

15743915

http://www.w3.org/2001/XMLSchema#string

P921

P932

554824

http://www.w3.org/2001/XMLSchema#string